Connective Tissue and Metabolic Coupling Models
The energy metabolism model can be extended to incorporate hypoxia-inducible factor-1\(\alpha\) (HIF-1\(\alpha\)) and extracellular matrix (ECM) dynamics, providing a mechanistic link between metabolic stress and connective tissue degradation observed in ME/CFS patients with comorbid hypermobile Ehlers-Danlos syndrome. Three new state variables extend the model: \([\text{HIF1}]\) (HIF-1\(\alpha\) concentration), \([\text{ECM}_q]\) (ECM quality/crosslinking), and \([\text{MMP}]\) (matrix metalloproteinase activity).
\[ \begin{aligned} \frac{d [\text{HIF1}]}{d t} &= k_{\text{HIF1}}^{\text{ROS}} \cdot [\text{ROS}] - k_{\text{HIF1}}^{\text{deg}} \cdot \frac{[\text{HIF1}]}{K_{\text{O2}} + [\text{O2}]} \\ \frac{d [\text{ECM}_q]}{d t} &= k_{\text{ECM}}^{\text{synth}} \cdot f_{\text{HIF1}}([\text{HIF1}]) - k_{\text{ECM}}^{\text{deg}} \cdot [\text{MMP}] \cdot [\text{ECM}_q] \\ \frac{d [\text{MMP}]}{d t} &= k_{\text{MMP}}^{\text{HIF1}} \cdot [\text{HIF1}] + k_{\text{MMP}}^{\text{inf}} \cdot [\text{IL-6}] - k_{\text{MMP}}^{\text{clear}} \cdot [\text{MMP}] \end{aligned} \]
where \(k_{\text{HIF1}}^{\text{ROS}}\) is ROS-mediated HIF-1α induction (normally inhibited by prolyl hydroxylase), the degradation term captures oxygen-dependent proteasomal degradation, ECM synthesis is upregulated by HIF-1α, and MMP induction responds to both HIF-1α and inflammatory cytokines. The ECM quality variable \([\text{ECM}_{q}]\) couples back to the energy model through the oxygen delivery equation: reduced vascular compliance from degraded ECM impairs tissue perfusion, lowering effective DO₂. This creates a positive feedback loop: energy deficit → ROS → HIF-1α → MMP → ECM degradation → reduced perfusion → exacerbated energy deficit. The model predicts specific temporal patterns of HIF-1α, MMP, and ECM markers (e.g., collagen turnover fragments) after exercise that match ME/CFS patient data and distinguish ME/CFS from healthy responses.
Certainty: 0.55. The HIF-1α-ECM coupling is well-established in tendinopathy (Moschini, Mohanan, et al. 2026), and the ROS-mediated HIF-1α stabilization mechanism is biochemically validated. The application to ME/CFS connective tissue comorbidity requires confirmation that ECM degradation contributes substantively to symptom burden, and that the temporal signatures (post-exertional MMP spikes) are present in ME/CFS with the predicted delay relative to ROS.
Connective tissue dysfunction in ME/CFS with hypermobility can be modeled through cumulative strain accumulation, providing a quantitative framework for why minor activities cause crashes. Define \([\text{strain}](t)\) as the cumulative connective tissue strain load and \(\theta_{\text{PEM}}\) as the PEM activation threshold:
\[ \begin{aligned} \frac{d [\text{strain}]}{d t} &= \sigma(t) - k_{\text{repair}} \cdot [\text{strain}] \\ \text{PEM}(t) &= \mathbb{1}_([\text{strain}](t) > \theta_{\text{PEM}}) \end{aligned} \]
where \(\sigma(t)\) is time-varying mechanical stress from activity, \(k_{\text{repair}}\) is tissue repair rate, and the indicator function triggers PEM when strain exceeds threshold. In healthy connective tissue, \(k_{\text{repair}}\) maintains strain within safe bounds; in ME/CFS with hEDS, \(k_{\text{repair}}\) is reduced due to collagen synthesis defects, impaired fibroblast function, and reduced ATP availability for matrix synthesis. This reduction shifts the equilibrium \(S^* = \sigma_0 / k_{\text{repair}}\) upward, making it easier to cross \(\theta_{\text{PEM}}\). The model explains why minor activities that are individually below threshold can trigger PEM when accumulated rapidly (inter-event interval less than \(\tau_{\text{repair}} = 1/k_{\text{repair}}\)). The threshold phenomenon also accounts for the observation that seemingly trivial activities (sitting upright, light walking) can cause crashes in severe patients: their repair capacity is so depleted that even low \(\sigma(t)\) produces net strain accumulation.
Certainty: 0.55. The strain-accumulation framework is standard in biomechanics and tissue engineering. The novel application to ME/CFS-PEM coupling requires validation that: (1) PEM onset correlates with strain accumulation patterns rather than immediate metabolic markers alone; (2) connective tissue repair rates are measurably reduced in ME/CFS (via collagen turnover markers); and (3) interventions that enhance repair (specific collagen support, improved substrate availability) raise \(k_{\text{repair}}\) and thereby widen the PEM threshold.